先天性左肝缺如合并肝细胞癌1例报告

王海林; 李敬东; 武国

doi:10.3969/j.issn.1001-5256.2023.06.023

先天性左肝缺如合并肝细胞癌1例报告

DOI: 10.3969/j.issn.1001-5256.2023.06.023

川北医学院附属医院肝胆外一科，四川南充 637000

基金项目:

南充市科技局市校合作基金 (19SXHZ0171);

川北医学院校级课题重点项目 (CBY18-A-ZD20);

川北医学院附属医院院级课题 (2019JC004)

伦理学声明：本例报告已获得患者家属知情同意。

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：王海林负责收集病例资料、检索文献及论文撰写；李敬东负责检索文献与论文修改；武国负责拟定写作思路、指导论文撰写与最终定稿。

详细信息

通信作者:
WANG Hailin, 361858598@qq.com (ORCID: 0000-0002-0406-6299)

计量
- 文章访问数: 263
- HTML全文浏览量: 57
- PDF下载量: 28
- 被引次数: 0
出版历程
- 收稿日期: 2022-10-30
- 录用日期: 2022-12-27
- 出版日期: 2023-06-20

Congenital left hepatic deficiency with hepatocellular carcinoma: A case report

First Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China

Research funding:

Science and Technology Cooperation Fund of Nanchong City and North Sichuan Medical College (19SXHZ0171);

Key Project of North Sichuan Medical College (CBY18-A-ZD20);

Fund of Affiliated Hospital of North Sichuan Medical College (2019JC004)

摘要

- 癌，肝细胞 /
- 消化系统畸形 /
- 左肝缺损 /
- 治疗学
- Carcinoma, Hepatocellular /
- Digestive System Abnormalities /
- Left Hepatic Defects /
- Therapeutics

HTML全文

图 1 治疗前上腹部增强CT检查结果

注：a，平扫期；b，动脉期；c，门静脉期。

Figure 1. Enhanced CT images of the patient's upper abdomen before treatment

下载: 全尺寸图片幻灯片

图 2 治疗后上腹部增强CT/CTA检查结果

注：a，平扫期；b，血管成像+重建；c，门静脉期。

Figure 2. Enhanced CT/CTA images of the patient's upper abdomen after treatment

下载: 全尺寸图片幻灯片

参考文献(19)

[1]	YAMAGUCHI Y, SHIRAKI K, YAMANAKA Y, et al. Agenesis of the right lobe of the liver with hilar cholangiocarcinoma[J]. J Clin Gastroenterol, 2004, 38(8): 723-724. DOI: 10.1097/01.mcg.0000135374.95598.62.
[2]	CHAMPETIER J, YVER R, LÉTOUBLON C, et al. A general review of anomalies of hepatic morphology and their clinical implications[J]. Anat Clin, 1985, 7(4): 285-299. DOI: 10.1007/BF01784645.
[3]	XU N, JIANG LS, YAN LN, et al. Split liver with intrahepatic bile duct calculus: a case report and literature review[J]. J Hepatopancreatobiliary Surg, 2010, 22(2): 132-135. DOI: 10.3969/j.issn.1007-1954.2010.02.018. 胥楠, 蒋力生, 严律南, 等. 分裂肝合并肝内胆管结石1例报告并文献复习[J]. 肝胆胰外科杂志, 2010, 22(2): 132-135. DOI: 10.3969/j.issn.1007-1954.2010.02.018.
[4]	PARKE WW, SETTLES HE, BUNGER PC, et al. Malformations of the liver: some prenatal and postnatal developmental aspects[J]. Clin Anat, 1996, 9(5): 309-316. DOI: 10.1002/(SICI)1098-2353(1996)9:5<309::AID-CA4>3.0.CO;2-7.
[5]	GATHWALA G, SEN J. Agenesis of the right lobe of liver[J]. Indian J Pediatr, 2003, 70(2): 183-184. DOI: 10.1007/BF02723752.
[6]	HSU KL, CHENG YF, KO SF. Hypoplastic right hepatic lobe with retrohepatic gallbladder complicated by hepatolithiasis and liver abscess: a case report[J]. Hepatogastroenterology, 1997, 44(15): 803-807.
[7]	HAN S, SOYLU L. Accessory liver lobe in the left thoracic cavity[J]. Ann Thorac Surg, 2009, 87(6): 1933-1934. DOI: 10.1016/j.athoracsur.2008.10.076.
[8]	MARTÍN MT, CARREIRA C, GÓMEZ D, et al. Mobile liver and colonic volvulus. A case report[J]. Radiologia, 2007, 49(6): 430-432. DOI: 10.1016/s0033-8338(07)73815-8.
[9]	DAVER GB, BAKHSHI GD, PATIL A, et al. Bifid liver in a patient with diaphragmatic hernia[J]. Indian J Gastroenterol, 2005, 24(1): 27-28.
[10]	ZHOU M, WANG H, ZENG X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. DOI: 10.1016/S0140-6736(19)30427-1.
[11]	CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
[12]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
[13]	VOGEL A, CERVANTES A, CHAU I, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(Suppl 4): iv238-iv255. DOI: 10.1093/annonc/mdy308.
[14]	ROBERTS LR, SIRLIN CB, ZAIEM F, et al. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis[J]. Hepatology, 2018, 67(1): 401-421. DOI: 10.1002/hep.29487.
[15]	General Office of National Health Commission. Standard for diagnosis and treatment of primary liver cancer (2022 edition)[J]. J Clin Hepatol, 2022, 38(2): 288-303. DOI: 10.3969/j.issn.1001-5256.2022.02.009. 国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(2): 288-303. DOI: 10.3969/j.issn.1001-5256.2022.02.009.
[16]	YUAN SX, ZHOU WP. Progress and hot spots of comprehensive treatment for primary liver cancer[J]. Chin J Dig Surg, 2021, 20(2): 163-170. DOI: 10.3760/cma.j.cn115610-20201211-00776. 袁声贤, 周伟平. 原发性肝癌综合治疗的进展和热点[J]. 中华消化外科杂志, 2021, 20(2): 163-170. DOI: 10.3760/cma.j.cn115610-20201211-00776.
[17]	WU HX, DING XY, CHEN JL. Treatment progress on unresectable advanced primary liver cancer with portal vein tumor thrombus[J/CD]. Chin J Liver Dis (Electronic Version), 2021, 13(4): 19-26. DOI: 10.3969/j.issn.1674-7380.2021.04.005. 吴泓晓, 丁晓燕, 陈京龙. 合并门静脉癌栓的不可切除晚期原发性肝癌治疗进展[J/CD]. 中国肝脏病杂志(电子版), 2021, 13(4): 19-26. DOI: 10.3969/j.issn.1674-7380.2021.04.005.
[18]	ZHU XD, HUANG C, SHEN YH, et al. Downstaging and resection of initially unresectable hepatocellular carcinoma with tyrosine kinase inhibitor and anti-PD-1 antibody combinations[J]. Liver Cancer, 2021, 10(4): 320-329. DOI: 10.1159/000514313.
[19]	PARK JW, CHEN M, COLOMBO M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study[J]. Liver Int, 2015, 35(9): 2155-2166. DOI: 10.1111/liv.12818.